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with Attention Deﬁcit/Hyperactivity Disorder (ADHD) in
children. The objective of this abstract is to present the
results on the burden (intangible costs) ADHD imposes
on the individual, the family and society in terms of
symptom persistence, violence, antisocial behaviour,
crime, substance misuse, social adjustment, academic 
performance. METHODS: The international literature
search was complemented by country-speciﬁc literature
searches in France, Germany, Italy, Netherlands, Spain
and the UK. In each country a clinical expert was inter-
viewed and reviewed the country-speciﬁc information.
RESULTS: Sources reporting the intangible conse-
quences/costs of ADHD were limited with literature from
the UK, France, Spain and Sweden. Literature suggests
that pervasively hyperactive symptoms in childhood is a
risk factor for poor outcomes in later development with
ADHD symptoms persisting into school leaving age and
nearly half of hyperactive children given a psychiatric
diagnosis. The literature review found reports indicating
that hyperactivity was a determinant of violence, aggres-
sion, deﬁant and disruptive behaviours, stealing, shoplift-
ing, joyriding, vandalism, offending and contact with the
police. Reports suggest a causal link between ADHD and
substance misuse but there is no consensus. Childhood
hyperactivity was reported to be a strong predictor of
relationship problems with links between hyperactivity
and moderate to severe problems in social functioning.
Reports from UK, France and Spain indicate that acade-
mic problems in school were more frequent in children
displaying hyperactive symptoms with language disor-
ders, reading, writing, cognitive and/or social develop-
ment difﬁculties. CONCLUSION: The consequences of
ADHD for the individual are potentially very severe and
we can infer this imposes a signiﬁcant burden upon the
family unit and society. ADHD symptoms can persist into
adolescence, and the hyperactive element of ADHD can
be predictive of violence, antisocial behaviour, crime,
poor social adjustment, substance abuse, and academic
problems.
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OBJECTIVE: An international literature review assessed
the epidemiology, treatment patterns and cost associated
with Attention Deﬁcit/Hyperactivity Disorder (ADHD) in
children. The objective of this abstract is to present the
results on deﬁnition of the disorder, diagnosis, prevalence,
demographics, age of onset and treatment guidelines,
treatment in Europe. METHODS: The international 
literature search was complemented by country-speciﬁc 
literature searches in France, Germany, Italy, Nether-
lands, Spain and the UK. In each country a clinical expert
was interviewed and reviewed the country-speciﬁc infor-
mation. RESULTS: Across Europe, literature reﬂects 
the use of both the ICD-10 deﬁnition of Hyperkinetic 
Disorder (HD), and the DSM-IV deﬁnition of ADHD. 
In Italy the DSM-III and DSM-IIIR deﬁnitions are also
reported. Diagnosis/treatment initiation is usually made
by child psychologists/psychiatrists and, increasingly, by
paediatricians. Estimates of prevalence vary widely
depending on the study population and diagnostic crite-
ria used. For the general population, estimates based on
the HD deﬁnition are in the range of 0.5–2.4% and those
based on the ADHD deﬁnition are in the range of 5–10%.
Reports from the UK and Germany indicated that features
of the disorder arise before the age of 5 years. One source
from Germany reported that symptom recognition
occurred on average at 10.2 years of age, with 9.4% of
the sample experiencing ﬁrst symptoms at 5 years of age
or younger. European treatment guidelines have been pub-
lished and country speciﬁc treatment guidelines also exist
in the UK, Netherlands, and Germany. Pharmacotherapy
in Europe is primarily through the use of psychostimu-
lants, although these are not generally available in Italy.
CONCLUSION: The literature review established that
ADHD/HD is a recognised disorder for children in Europe.
Formal criteria are used to diagnose the disorder, studies
have measured the prevalence, demographics, age of onset
and treatment guidelines have been published.
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OBJECTIVE: An international literature review assessed
the epidemiology, treatment patterns and costs associated
with Attention Deﬁcit/Hyperactivity Disorder (ADHD) in
children. The objective of this abstract is to present the
results on deﬁnition, gender characteristics, recognition,
delay between onset and diagnosis. METHODS: The
international literature search was complemented by
country-speciﬁc literature searches in France, Germany,
Italy, Netherlands, Spain and the UK. In each country, a
clinical expert was interviewed and reviewed the country-
speciﬁc information. RESULTS: Deﬁnition of ADHD is
not uniform across countries as the literature reﬂects 
the use of both the ICD-10 deﬁnition of Hyperkinetic 
Disorder (HD), and the DSM-IV deﬁnition of ADHD.
DSM-IV offers a broader, more encompassing deﬁnition
of ADHD when compared to HD. Reports of male to
female prevalence found conﬂicting evidence as male
cases may outnumber females by as much as 9 :1, but
other sources reported a 1 :1 ratio. ADHD/HD differ-
ences in gender is currently debated with the view that
boys exhibit more distinguishable symptoms. The litera-
ture indicated that diagnosis may be complicated by many
